Hormone support for fertility preservation in cancer patients
Part of Women’s health & pregnancy clinical trials.
This study tests whether adding a second hormone (LH) to the usual stimulation medicines improves egg or embryo freezing outcomes for cancer patients who need fertility preservation. It may help more eggs or embryos be collected safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 40 years old.
- You are planning IVF to freeze eggs or embryos for fertility preservation.
- You have a cancer diagnosis that is not breast, uterine, or ovarian cancer.
- You have not had chemotherapy or radiation to the abdomen or pelvis before.
- You do not have any blood clotting problems or previous blood clots.
- You do not have untreated thyroid or adrenal gland issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps people with cancer preserve their fertility (ability to have biological children) before undergoing cancer treatment that could affect their eggs or sperm. The trial compares two different hormone-injection methods to prepare eggs for freezing.
This trial compares two hormone protocols for ovarian stimulation in women having their first cycle—either to freeze eggs for fertility preservation or for IVF with genetic testing. The goal is to see which method leads to more usable eggs while being easier on the patient.
This study looks at whether a blood test (a hormone marker) can predict a child’s future risk of infertility after cancer treatment. If it works, it could help families and doctors plan earlier fertility and puberty-related care.
This trial tests whether giving extra luteinizing hormone (LH) can improve embryo quality in women with very low LH levels during IVF. It may help you if you have low LH and are using a specific type of fertility medication.
This study tests whether giving an extra hormone called LH before egg retrieval helps improve IVF outcomes for women with naturally low LH levels. If you qualify, you may receive this added hormone to see if it helps your eggs mature better.
This trial tests whether giving a medication called a GnRH agonist during the luteal phase (the time after egg retrieval) can help with IVF success. It is for people who are using a specific medication protocol (recombinant FSH with an antagonist) and have certain hormone levels.
Hear when a new Fertility Preservation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.